These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19625396)

  • 1. The six-helix bundle of human immunodeficiency virus Env controls pore formation and enlargement and is initiated at residues proximal to the hairpin turn.
    Markosyan RM; Leung MY; Cohen FS
    J Virol; 2009 Oct; 83(19):10048-57. PubMed ID: 19625396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation.
    Markosyan RM; Cohen FS; Melikyan GB
    Mol Biol Cell; 2003 Mar; 14(3):926-38. PubMed ID: 12631714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
    Keller PW; Morrison O; Vassell R; Weiss CD
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations That Increase the Stability of the Postfusion gp41 Conformation of the HIV-1 Envelope Glycoprotein Are Selected by both an X4 and R5 HIV-1 Virus To Escape Fusion Inhibitors Corresponding to Heptad Repeat 1 of gp41, but the gp120 Adaptive Mutations Differ between the Two Viruses.
    Zhuang M; Vassell R; Yuan C; Keller PW; Ling H; Wang W; Weiss CD
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of low pH-induced refolding of Env of avian sarcoma and leukosis virus into a six-helix bundle.
    Markosyan RM; Bates P; Cohen FS; Melikyan GB
    Biophys J; 2004 Nov; 87(5):3291-8. PubMed ID: 15339808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-helix bundle completion in the distal C-terminal heptad repeat region of gp41 is required for efficient human immunodeficiency virus type 1 infection.
    Liu D; Wang H; Yamamoto M; Song J; Zhang R; Du Q; Kawaguchi Y; Inoue JI; Matsuda Z
    Retrovirology; 2018 Apr; 15(1):27. PubMed ID: 29609648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus (HIV) gp41 escape mutants: cross-resistance to peptide inhibitors of HIV fusion and altered receptor activation of gp120.
    Desmezieres E; Gupta N; Vassell R; He Y; Peden K; Sirota L; Yang Z; Wingfield P; Weiss CD
    J Virol; 2005 Apr; 79(8):4774-81. PubMed ID: 15795263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of the membrane proximal heptad repeat of the newcastle disease virus fusion protein.
    McGinnes LW; Sergel T; Chen H; Hamo L; Schwertz S; Li D; Morrison TG
    Virology; 2001 Oct; 289(2):343-52. PubMed ID: 11689056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of Glu560 within HIV-1 Envelope Glycoprotein N-terminal heptad repeat region contribute to resistance to peptide inhibitors of virus entry.
    Yuan C; Wang JY; Zhao HJ; Li Y; Li D; Ling H; Zhuang M
    Retrovirology; 2019 Dec; 16(1):36. PubMed ID: 31796053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hydrophobic pocket contributes to the structural stability of the N-terminal coiled coil of HIV gp41 but is not required for six-helix bundle formation.
    Dwyer JJ; Hasan A; Wilson KL; White JM; Matthews TJ; Delmedico MK
    Biochemistry; 2003 May; 42(17):4945-53. PubMed ID: 12718536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of residues in the coiled-coil domain of human immunodeficiency virus type 1 transmembrane protein gp41.
    Weng Y; Weiss CD
    J Virol; 1998 Dec; 72(12):9676-82. PubMed ID: 9811701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion intermediates of HIV-1 gp41 as targets for antibody production: design, synthesis, and HR1-HR2 complex purification and characterization of generated antibodies.
    Mzoughi O; Gaston F; Granados GC; Lakhdar-Ghazal F; Giralt E; Bahraoui E
    ChemMedChem; 2010 Nov; 5(11):1907-18. PubMed ID: 20922745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process.
    Gallo SA; Puri A; Blumenthal R
    Biochemistry; 2001 Oct; 40(41):12231-6. PubMed ID: 11591141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle.
    Abrahamyan LG; Mkrtchyan SR; Binley J; Lu M; Melikyan GB; Cohen FS
    J Virol; 2005 Jan; 79(1):106-15. PubMed ID: 15596806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion.
    Abrahamyan LG; Markosyan RM; Moore JP; Cohen FS; Melikyan GB
    J Virol; 2003 May; 77(10):5829-36. PubMed ID: 12719576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The membrane proximal external region of the HIV-1 envelope glycoprotein gp41 contributes to the stabilization of the six-helix bundle formed with a matching N' peptide.
    Noah E; Biron Z; Naider F; Arshava B; Anglister J
    Biochemistry; 2008 Jul; 47(26):6782-92. PubMed ID: 18540633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fusion core complex of the peste des petits ruminants virus is a six-helix bundle assembly.
    Rahaman A; Srinivasan N; Shamala N; Shaila MS
    Biochemistry; 2003 Feb; 42(4):922-31. PubMed ID: 12549911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-ray Structures of the Post-fusion 6-Helix Bundle of the Human Syncytins and their Functional Implications.
    Ruigrok K; Vaney MC; Buchrieser J; Baquero E; Hellert J; Baron B; England P; Schwartz O; Rey FA; Backovic M
    J Mol Biol; 2019 Dec; 431(24):4922-4940. PubMed ID: 31711961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type 1 variants resistant to first- and second-version fusion inhibitors and cytopathic in ex vivo human lymphoid tissue.
    Chinnadurai R; Rajan D; Münch J; Kirchhoff F
    J Virol; 2007 Jun; 81(12):6563-72. PubMed ID: 17428857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical resistance to enfuvirtide does not affect susceptibility of human immunodeficiency virus type 1 to other classes of entry inhibitors.
    Ray N; Harrison JE; Blackburn LA; Martin JN; Deeks SG; Doms RW
    J Virol; 2007 Apr; 81(7):3240-50. PubMed ID: 17251281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.